Evolutionary Genomics, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents

Evolutionary Genomics, Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents

Evolutionary Genomics, Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents of $82.00 thousand as of 2016-12-31, per its 10-K filed 2017-02-10.

Discontinued › Notes › Business Combination, Recognized Asset Acquired, Asset

us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents · last filed 2017-02-10

• 2016-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $82.00K.
• 2015-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $82.00K.
• 2015-10-19: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents $82.00K.